ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
62.19
+0.84 (1.37%)
At close: Jul 19, 2024, 4:30 PM
62.20
+0.01 (0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 83.67, with a low estimate of 77 and a high estimate of 94. The average target predicts an increase of 34.54% from the current stock price of 62.19.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ANIP stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $87 → $94 | Strong Buy | Maintains | $87 → $94 | +51.15% | Jun 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $83 → $87 | Strong Buy | Maintains | $83 → $87 | +39.89% | May 13, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +23.81% | Apr 23, 2024 |
| Capital One | Capital One | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 15, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $70 → $77 | Strong Buy | Maintains | $70 → $77 | +23.81% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
553.46M
from 486.82M
Increased by 13.69%
Revenue Next Year
590.20M
from 553.46M
Increased by 6.64%
EPS This Year
4.58
from 0.85
Increased by 438.32%
EPS Next Year
5.09
from 4.58
Increased by 11.19%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 578.3M | 615.4M | 659.0M | 698.7M | 738.5M |
| Avg | 553.5M | 590.2M | 625.4M | 654.1M | 680.2M |
| Low | 526.8M | 554.8M | 591.0M | 614.2M | 622.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 18.8% | 11.2% | 11.7% | 11.7% | 12.9% |
| Avg | 13.7% | 6.6% | 6.0% | 4.6% | 4.0% |
| Low | 8.2% | 0.2% | 0.1% | -1.8% | -4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.85 | 5.61 | 6.31 | 6.93 | 7.73 |
| Avg | 4.58 | 5.09 | 5.69 | 6.25 | 7.03 |
| Low | 4.21 | 4.43 | 5.03 | 5.16 | 5.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 470.7% | 22.5% | 24.0% | 21.7% | 23.7% |
| Avg | 438.3% | 11.2% | 11.9% | 9.7% | 12.5% |
| Low | 395.8% | -3.2% | -1.2% | -9.3% | -4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.